A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Acute limb ischemia in cancer patients: should we surgically intervene? | LitMetric

Acute limb ischemia in cancer patients: should we surgically intervene?

Ann Vasc Surg

Department of Vascular Surgery, Royal College of Surgeons Ireland, Beaumont Hospital, Dublin, Ireland.

Published: October 2011

AI Article Synopsis

  • Cancer patients face a higher risk of venous thromboembolic events, and some chemotherapy drugs have been linked to these complications, although acute arterial ischemia is less commonly reported.
  • In a study over 10 years at a university hospital, 16 out of 419 patients who underwent surgery for acute limb ischemia were found to have cancer, with common cases involving urogenital and lung cancers.
  • The majority of these patients received surgical intervention, but there was a notable rate of limb loss and in-patient mortality, pointing to the importance of early diagnosis and treatment in improving survival chances.

Article Abstract

Background: Cancer patients have an increased risk of venous thromboembolic events. Certain chemotherapeutic agents have also been associated with the development of thrombosis. Reported cases of acute arterial ischemic episodes in cancer patients are rare.

Methods: Patients who underwent surgery for acute limb ischemia associated with malignancy in a university teaching hospital over a 10-year period were identified. Patient demographics, cancer type, chemotherapy use, site of thromboembolism, treatment and outcome were recorded.

Results: Four hundred nineteen patients underwent surgical intervention for acute arterial ischemia, 16 of these patients (3.8%) had associated cancer. Commonest cancer sites were the urogenital tract (n = 5) and the lungs (n = 5). Eight patients (50%) had been recently diagnosed with cancer, and four (25%) of these cancers were incidental findings after presentation with acute limb ischemia. Four patients (25%) developed acute ischemia during chemotherapy. The superficial femoral artery was the most frequent site of occlusion (50%), followed by the brachial (18%) and popliteal (12%) arteries. All patients underwent thromboembolectomy, but two (12%) patients subsequently required a bypass procedure. Six patients (37%) had limb loss, and in-patient mortality was 12%. Histology revealed that all occlusions were due to thromboembolism, with no tumor cells identified. At follow-up, 44% of patients were found to be alive after 1 year.

Conclusion: Cancer and chemotherapy can predispose patients to acute arterial ischemia. Unlike other reports that view this finding as a preterminal event most appropriately treated by palliative measures, in this series, early diagnosis and surgical intervention enabled limb salvage and patient survival.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.avsg.2011.06.002DOI Listing

Publication Analysis

Top Keywords

patients
13
acute limb
12
limb ischemia
12
cancer patients
12
acute arterial
12
patients underwent
12
cancer
8
surgical intervention
8
arterial ischemia
8
ischemia patients
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!